ORGANIC
LETTERS
2008
Vol. 10, No. 5
829-832
Palladium-Catalyzed Cyclocarbonylation
of o-Iodoanilines with Imidoyl Chlorides
to Produce Quinazolin-4(3H)-ones
Zhaoyan Zheng and Howard Alper*
Centre for Catalysis Research and InnoVation, Department of Chemistry,
UniVersity of Ottawa, 10 Marie Curie, Ottawa, Ontario K1N 6N5, Canada
Received December 5, 2007
ABSTRACT
A wide variety of substituted quinazolin-4(3H)-ones were prepared in 63−91% yields by the palladium-catalyzed cyclocarbonylation of o-iodoanilines
with imidoyl chlorides and carbon monoxide. The reaction is believed to proceed via in situ formation of an amidine, followed by oxidative
addition, CO insertion, and intramolecular cyclization to give the substituted quinazolin-4(3H)-ones.
Quinazolin-4(3H)-ones are an important class of fused
heterocyclic compounds known as the core structural skeleton
in a variety of natural products and synthetic drugs.1 They
exhibit a wide range of biological activities such as anti-
cancer,2 antidiabetic,3 antiinflammatory,4 antimicrobial,5 an-
ticonvulsant,6 antibacterial,7 antimalarial,8 antiallergy,9 and
analgesic10 properties. There are a number of synthetic
methods available for the preparation of quinazolin-4(3H)-
ones.11 The most common synthetic route involves the
amidation of 2-aminobenzoic acid or its derivatives, i.e.,
2-aminobenzonitrile, 2-aminobenzoate, and 2-arylnitrilium
salts, followed by oxidative ring closure.12,13 Other synthetic
pathways include the cyclization of anthranilamides with
aldehydes,14 and with ketones or acid chlorides under acidic
or basic conditions.15 These traditional methods often suffer
from low yields, multistep reactions, or harsh reaction
conditions. Recently, several new synthetic methods were
reported including solid-phase synthesis,16 microwave ir-
radiation,17 and ionic liquid as a medium.18 A few examples
(1) (a) Jang, C. S.; Fu, F. Y.; Wang, C. Y.; Huang, K. C.; Lu, G.; Thou,
T. C. Science 1946, 103, 59. (b) D’yakonor, A. L.; Telezhenetskaya, M. V.
Chem. Nat. Comput. 1997, 33, 221. (c) Michael, J. P. Nat. Prod. Rep. 2004,
21, 650. (d) Mhaske, S. B.; Argade, N. P. Tetrahedron 2006, 62, 9787.
(2) (a) Jiang, J. B.; Hesson, D. P.; Dusak, B. A.; Dexter, D. L.; Kang,
G. J.; Hamel, E. J. Med. Chem. 1990, 33, 1721. (b) Cao, S. L.; Feng, Y. P.;
Jiang, Y. Y.; Liu, S. Y.; Ding, G. Y.; Li, R. T. Bioorg. Med. Chem. Lett.
2005, 15, 1915.
(3) Malamas, M. S.; Millen, J. J. Med. Chem. 1991, 34, 1492.
(4) Lowe, J. A.; Archer, R. L.; Chapin, D. S.; Cheng, J. B.; Helweg, D.;
Johnson, J. L.; Koe, B. K.; Lebel, L. A.; Moore, P. F.; Nielsen, J. A.; Russo,
L. L.; Shirley, J. T. J. Med. Chem. 1991, 34, 624.
(10) Fisnerova, L.; Brunova, B.; Kocfeldova, Z.; Tikalova, J.; Maturova,
E.; Grimova, Collect. Czech. Chem. Commun. 1991, 56, 2373.
(11) For a review: Connolly, D. J.; Cusack, D.; O’Sullivan, T. P.; Guiry,
P. J. Tetrahedron 2005, 61, 10153.
(12) (a) Bogert, M. T.; Hand, W. F. J. Am. Chem. Soc. 1902, 24, 1031.
(b) Bogert, M. T.; Hand, W. F. J. Am. Chem. Soc. 1903, 25, 935. (c) Stephen,
H.; Wadge, G. J. Chem. Soc. 1956, 4420. (d) Taylor, E. C.; Knopf, R. I.;
Borror, A. L. J. Am. Chem. Soc. 1960, 82, 3152. (e) Bogentoft, C.; Kronberg,
L.; Danielessan, B. Acta Pharm. Suec. 1969, 6, 485.
(5) (a) Habib, O. M.; Moawad, E. B.; Girges, M. M.; El-Shafei, A. M.
Boll. Chim. Farm. 1995, 134, 503. (b) Ibrahim, S. S.; Abdel-Halim, A. M.;
Gabr, Y.; El-Edfawy, S.; Abdel-Rahman, R. J. Chem. Res., Synop. 1997,
154.
(6) (a) Mannscherck, A.; Koller, H.; Stuhler, G.; Davis, M. A.; Traber,
J. Eur. J. Med. Chem. 1984, 19, 381. (b) Hori, M.; Iemura, R.; Hara, H.;
Ozaki, A.; Sukamoto, T.; Ohtaka, H. Chem. Pharm. Bull. 1990, 38, 1286.
(7) Kung, P. P.; Casper, M. D.; Cook, K. L.; Wilson-Lingard, L.; Risen,
L. M.; Vickers, T. A.; Ranken, R.; Blyn, L. B.; Wyatt, R.; Cook, P. D.;
Ecker, D. J. J. Med. Chem. 1999, 42, 4705.
(8) Kobayashi, S.; Ueno, M.; Suzuki, R.; Ishitani, H. Tetrahedron Lett.
1999, 40, 2175.
(9) LeMahieu, R. A.; Carson, M.; Nason, W. C.; Parrish, D. R.; Welton,
A. F.; Baruth, H. W.; Yaremko, B. J. Med. Chem. 1983, 26, 420.
(13) (a) Ozaki, K.; Yamada, Y.; Oine, T.; Ishizuka, T.; Iwasawa, Y. J.
Med. Chem. 1985, 28, 568. (b) Segarra, V.; Crespo, M. I.; Pujol, F.; Belata,
J.; Domenech, T.; Miralpix, M.; Palacios, J. M.; Castro, A. Bioorg. Med.
Chem. Lett. 1998, 8, 505. (c) Kotsuki, H.; Sakai, H.; Morimoto, H.; Suenaga,
H. Synlett 1999, 1993.
(14) Abdel-Jalil, R. J.; Volter, W.; Saeed, M. Tetrahedron Lett. 2004,
45, 3475.
(15) (a) Feldman, J. R.; Wagner, E. C. J. Org. Chem. 1942, 7, 31. (b)
Yale, H. L. J. Heterocycl. Chem. 1977, 14, 1357. (c) Mhaske, S. B.; Argade,
N. R. J. Org. Chem. 2004, 69, 4563.
10.1021/ol7029454 CCC: $40.75
© 2008 American Chemical Society
Published on Web 02/05/2008